Aquaculture Innovator Benchmark Holdings Prepares Strategic Realignment and Return of Capital, Declares Debt-Free Status

Aquaculture biotechnology heavyweight, Benchmark Holdings has revealed exciting strategic updates and ambitious plans for a future return of capital. This announcement comes on the back of the company’s successful completion of its Green Bond redemption, positioning it as debt-free and solidifying its standing in the global market. Following the sale of Genetics, the company is making significant headway in streamlining its corporate structure, priming it for the next phase of growth and excellence.

In May, the company is set to provide further details on its progressive strategy and plans for the capital return. This places Benchmark at a significant precipice of growth and will engender an opportunity often sought by investors.

This new strategic overhaul and the successful balance sheet manoeuvre mark a thrilling chapter and assert Benchmark’s influence in steering the future of the aquaculture biotech sector.